Patents by Inventor Xiaoling Wu

Xiaoling Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220010029
    Abstract: A hybridoma cell strain secreting anti-dinitolmide monoclonal antibodies deposited at China General Microbiological Culture Collection Center (CGMCC) at No. 1 West Beichen Road, Chaoyang District, Beijing 100101, China on Nov. 28, 2019, with deposit number of CGMCC No. 19165. It is classified as a monoclonal cell strain. The monoclonal antibody secreted by the hybridoma cell strain DAS3H10 has a good affinity and high sensitivity to dinitolmide. Because of IC50 to dinitolmide up to 9.01 ng/mL, the monoclonal antibody could be used to prepare dinitolmide immunoassay kit and colloidal gold test strip and provides a powerful detection method and means for the detection of dinitolmide in animal-derived foods.
    Type: Application
    Filed: July 6, 2021
    Publication date: January 13, 2022
    Inventors: Chuanlai XU, JIE LIU, HUA KUANG, Liguang XU, Maozhong SUN, Liqiang LIU, Xiaoling WU, Changlong HAO, Shanshan SONG, Yongming HU, Qiankun ZHENG
  • Publication number: 20210408507
    Abstract: A pixel bank manufacturing method, a pixel bank structure, a pixel structure, and a display panel are provided. The method includes providing a base substrate, wherein a plurality of anode thin film layers are manufactured on the base substrate; coating a photoresist layer used for covering the plurality of anode thin film layers on the base substrate; performing a photolithography on the photoresist layer by an exposing patterning structure, and baking to cure a remained photoresist layer after the photolithography to form a first bank layer; the exposing patterning structure is a structure that full via holes, first half via holes, a plurality of blind via holes, and second half via holes are arranged repeatedly; forming a second bank layer on the first bank layer; the second bank layer is a black bank layer.
    Type: Application
    Filed: April 22, 2020
    Publication date: December 30, 2021
    Applicant: Shenzhen China Star Optoelectronic Semiconductor Display Technology Co., Ltd.
    Inventor: Xiaoling WU
  • Publication number: 20210198679
    Abstract: A Saccharomyces cerevisiae strain with high yield of ethyl butyrate and a construction method and an application thereof are provided. The strain is obtained by over-expressing in the starting strain acetyl coenzyme A acyl transferase gene Erg10, 3-hydroxybutyryl coenzyme A dehydrogenase gene Hbd, 3-hydroxybutyryl coenzyme A dehydratase gene Crt, trans-2-enoyl coenzyme A reductase gene Ter, and alcohol acyl transferase gene AAT. Compared to the starting bacteria not producing ethyl butyrate, the yield of ethyl butyrate of the constructed strain reaches 77.33±3.79 mg/L, the yield of the ethyl butyrate of the strain with double copy expression of gene Ter and gene AAT reaches 99.65±7.32 mg/L, increased by 28.9% compared with the EST strain, and 40.93±3.18 mg/L of ethyl crotonate is unexpectedly produced.
    Type: Application
    Filed: December 25, 2020
    Publication date: July 1, 2021
    Applicant: Tianjin University of Science and Technology
    Inventors: Yefu CHEN, Yanrui MA, Yongjing DU, Sen JIANG, Jinying REN, Guo ZHANG, Xinyue KANG, Peng ZHENG, Xiaole WU, Dongguang XIAO, Xuewu GUO
  • Patent number: 10882896
    Abstract: A hybridoma cell strain secreting a nifursol residue marker monoclonal antibody prepared in the following way: BALB/c mice are subjected to the first immunization with a complete Freund's adjuvant, subjected to booster immunization with an incomplete Freund's adjuvant for four times, and subjected to rush immunization once with nifursol residue marker complete antigen without a Freund's adjuvant so that the BALB/c mice are immunized; the spleen cells of the immunized mice with high titer and low IC50 were fused with mouse myeloma cells by a PEG method, and the fused cells are screened through indirect competitive ELISA and subcloned three times. The monoclonal antibody secreted by this cell strain has good specificity and detection sensitivity (IC50 value of 2 ?g/L) to the nifursol residue marker and can be used for residue detection of the nifursol residual marker in food.
    Type: Grant
    Filed: July 21, 2020
    Date of Patent: January 5, 2021
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Hua Kuang, Chuanlai Xu, Aihong Wu, Liguang Xu, Wei Ma, Liqiang Liu, Xiaoling Wu, Shanshan Song, Yongming Hu
  • Publication number: 20200347119
    Abstract: A hybridoma cell strain secreting a nifursol residue marker monoclonal antibody prepared in the following way: BALB/c mice are subjected to the first immunization with a complete Freund's adjuvant, subjected to booster immunization with an incomplete Freund's adjuvant for four times, and subjected to rush immunization once with nifursol residue marker complete antigen without a Freund's adjuvant so that the BALB/c mice are immunized; the spleen cells of the immunized mice with high titer and low IC50 were fused with mouse myeloma cells by a PEG method, and the fused cells are screened through indirect competitive ELISA and subcloned three times. The monoclonal antibody secreted by this cell strain has good specificity and detection sensitivity (IC50 value of 2 ?g/L) to the nifursol residue marker and can be used for residue detection of the nifursol residual marker in food.
    Type: Application
    Filed: July 21, 2020
    Publication date: November 5, 2020
    Inventors: Hua KUANG, Chuanlai XU, Aihong WU, Liguang XU, Wei MA, Liqiang LIU, Xiaoling WU, Shanshan SONG, Yongming HU
  • Patent number: 10808041
    Abstract: The present disclosure discloses a lincosamides universal monoclonal antibody hybridoma cell strain and application thereof, and belongs to the technical field of food safety immunological detection. According to the present disclosure, a clindamycin chlorine-substituted derivative is used as a hapten, the hapten is coupled with bovine serum albumin (BSA) by an activated ester method to obtain an immunizing antigen, and after being uniformly mixed with a Freund's adjuvant, the immunizing antigen is subcutaneously injected to immunize BALB/c mice; clindamycin is coupled with ovalbumin (OVA) by a carbonyl diimidazole (CDI) method to be used as a coating antigen used for detecting mouse serums and a cell supernatant. The spleen cells of the immunized mice are fused with mouse myeloma cells by a PEG method, and screened by indirect ELISA and indirect competitive ELISA and subcloned three times to obtain a population-selective hybridoma cell strain.
    Type: Grant
    Filed: November 28, 2019
    Date of Patent: October 20, 2020
    Assignee: Jiangnan University
    Inventors: Hua Kuang, Lingling Guo, Chuanlai Xu, Liguang Xu, Wei Ma, Liqiang Liu, Shanshan Song, Xiaoling Wu
  • Patent number: 10759845
    Abstract: A hybridoma cell strain secreting a nifursol residue marker monoclonal antibody with CGMCC No. 18525 is prepared in the following way: BALB/c mice are subjected to the first immunization with a complete Freund's adjuvant, subjected to booster immunization with an incomplete Freund's adjuvant for four times, and subjected to rush immunization once with nifursol residue marker complete antigen without a Freund's adjuvant so that the BALB/c mice are immunized; the spleen cells of the immunized mice with high titer and low IC50 were fused with mouse myeloma cells by a PEG method, and the fused cells are screened through indirect competitive ELISA and subcloned three times. The monoclonal antibody secreted by this cell strain has good specificity and detection sensitivity (IC50 value of 2 ?g/L) to the nifursol residue marker and can be used for residue detection of the nifursol residual marker in food.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: September 1, 2020
    Inventors: Hua Kuang, Chuanlai Xu, Aihong Wu, Liguang Xu, Wei Ma, Liqiang Liu, Xiaoling Wu, Shanshan Song, Yongming Hu
  • Patent number: 10696748
    Abstract: A hybridoma cell line of secreting clarithromycin monoclonal antibodies with a preservation number of hybridoma cell line of CGMCC No. 14696 belongs to the field of food safety immunological detection. BALB/c mice are immunized through one time immunization with complete freund's adjuvant, three times of booster immunization with incomplete freund's adjuvant and one time of rush immunization with clarithromycin complete antigen without adjuvant; the spleen cells from BALB/C mice immunized with high potency and low value of IC50 are fused with murine myeloma cells; and then the hybridoma cell line is obtained through indirect competitive ELISA screening and three subclones. The monoclonal antibody secreted by this cell line has good specificity and detection sensitivity to clarithromycin (value of IC50 is 0.3 ng/ml), being suitable for detection of clarithromycin in food.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: June 30, 2020
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Chuanlai Xu, Hua Kuang, Lu Zeng, Liguang Xu, Liqiang Liu, Shanshan Song, Xiaoling Wu, Yongming Hu
  • Publication number: 20200168834
    Abstract: The present invention provides an OLED element and a manufacture method thereof. A cathode contact layer spaced from the anode layer is provided on the substrate of the organic light emitting diode element. The cathode layer contacts the cathode contact layer through the cathode contact hole in the pixel definition layer. As the organic light emitting diode element works, the same negative voltage is applied to the cathode layer and the cathode contact layer. The cathode contact layer can directly provide voltage and current compensations to the cathode layer, thus to prevent uneven brightness due to IR Drop appearing to a large scale organic light emitting diode display panel. The manufacturing method of the organic light emitting diode element can effectively prevent IR Drop for the organic light emitting diode element and can further improve an uneven brightness of an organic light emitting diode display panel.
    Type: Application
    Filed: September 6, 2018
    Publication date: May 28, 2020
    Inventors: Yifei BING, Tsungyuan WU, Xiaoling WU
  • Publication number: 20200095337
    Abstract: The present disclosure discloses a lincosamides universal monoclonal antibody hybridoma cell strain and application thereof, and belongs to the technical field of food safety immunological detection. According to the present disclosure, a clindamycin chlorine-substituted derivative is used as a hapten, the hapten is coupled with bovine serum albumin (BSA) by an activated ester method to obtain an immunizing antigen, and after being uniformly mixed with a Freund's adjuvant, the immunizing antigen is subcutaneously injected to immunize BALB/c mice; clindamycin is coupled with ovalbumin (OVA) by a carbonyl diimidazole (CDI) method to be used as a coating antigen used for detecting mouse serums and a cell supernatant. The spleen cells of the immunized mice are fused with mouse myeloma cells by a PEG method, and screened by indirect ELISA and indirect competitive ELISA and subcloned three times to obtain a population-selective hybridoma cell strain.
    Type: Application
    Filed: November 28, 2019
    Publication date: March 26, 2020
    Inventors: Hua KUANG, Lingling GUO, Chuanlai XU, Liguang XU, Wei MA, Liqiang LIU, Shanshan SONG, Xiaoling WU
  • Patent number: 10562979
    Abstract: A hybridoma cell line of secreting meloxicam monoclonal antibodies with a preservation number of hybridoma cell line of CGMCC No. 14700 belongs to the field of food safety immunological detection. The. BALB/c mice are immunized through one time immunization with complete freund's adjuvant, three times of booster immunization with incomplete freund's adjuvant and one time of rush immunization with meroxicam complete antigen without adjuvant; the spleen cells from BALB/C mice immunized with high potency and low value of IC50 are fused with murine myeloma cells; and then the hybridoma cell line is obtained through indirect competitive ELISA screening and three sub-clones. The monoclonal antibody secreted by this cell line has good specificity and detection sensitivity to meloxicam (value of IC50 is 0.1 ng/ml), being suitable for detection of meroxicam in food.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: February 18, 2020
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Hua Kuang, Chuanlai Xu, Lu Lin, Liguang Xu, Wei Ma, Liqiang Liu, Xiaoling Wu, Shanshan Song, Yongming Hu
  • Publication number: 20200048329
    Abstract: A hybridoma cell strain secreting a nifursolol residue marker monoclonal antibody with CGMCC No. 14698 is prepared in the following way: BALB/c mice are subjected to the first immunization with a complete Freund's adjuvant, subjected to booster immunization with an incomplete Freund's adjuvant for four times, and subjected to rush immunization once with nifursolol residue marker complete antigen without a Freund's adjuvant so that the BALB/c mice are immunized; the spleen cells of the immunized mice with high titer and low IC50 were fused with mouse myeloma cells by a PEG method, and the fused cells are screened through indirect competitive ELISA and subcloned three times. The monoclonal antibody secreted by this cell strain has good specificity and detection sensitivity (IC50 value of 2 ?g/L) to the nifursolol residue marker and can be used for residue detection of the nifursolol residual marker in food.
    Type: Application
    Filed: December 17, 2018
    Publication date: February 13, 2020
    Inventors: Hua KUANG, Chuanlai XU, Aihong WU, Liguang XU, Wei MA, Liqiang LIU, Xiaoling WU, Shanshan SONG, Yongming HU
  • Publication number: 20200040106
    Abstract: A hybridoma cell line of secreting meloxicam monoclonal antibodies with a preservation number of hybridoma cell line of CGMCC No. 14700 belongs to the field of food safety immunological detection. The. BALB/c mice are immunized through one time immunization with complete freund's adjuvant, three times of booster immunization with incomplete freund's adjuvant and one time of rush immunization with meroxicam complete antigen without adjuvant; the spleen cells from BALB/C mice immunized with high potency and low value of IC50 are fused with murine myeloma cells; and then the hybridoma cell line is obtained through indirect competitive ELISA screening and three sub-clones. The monoclonal antibody secreted by this cell line has good specificity and detection sensitivity to meloxicam (value of IC50 is 0.1 ng/ml), being suitable for detection of meroxicam in food.
    Type: Application
    Filed: December 17, 2018
    Publication date: February 6, 2020
    Inventors: Hua KUANG, Chuanlai XU, Lu LIN, Liguang XU, Wei MA, Liqiang LIU, Xiaoling WU, Shanshan SONG, Yongming HU
  • Publication number: 20190284303
    Abstract: A hybridoma cell line of secreting cyproheptadine monoclonal antibodies with a preservation number of CGMCC No. 14699 belongs to the field of food safety immunological detection. BALB/c mice are immunized through one time immunization with complete freund's adjuvant, three times of booster immunization with incomplete freund's adjuvant and one time of rush immunization with cyproheptadine complete antigen without adjuvant; the spleen cells from BALB/C mice immunized with high potency and low value of IC50 are fused with murine myeloma cells; and then the hybridoma cell line is obtained through indirect competitive ELISA screening and three sub-clones. The monoclonal antibody secreted by this cell line has good specificity and detection sensitivity to cyproheptadine (value of IC50 is 0.37 ng/ml), being suitable for detection of cyproheptadine in food.
    Type: Application
    Filed: December 17, 2018
    Publication date: September 19, 2019
    Inventors: Chuanlai XU, Hua KUANG, Wei JIANG, Liguang XU, Wei MA, Liqiang LIU, Xiaoling WU, Shanshan SONG, Yongming HU
  • Publication number: 20190284304
    Abstract: A hybridoma cell line of secreting clarithromycin monoclonal antibodies with a preservation number of hybridoma cell line of CGMCC No. 14696 belongs to the field of food safety immunological detection. BALB/c mice are immunized through one time immunization with complete freund's adjuvant, three times of booster immunization with incomplete freund's adjuvant and one time of rush immunization with clarithromycin complete antigen without adjuvant; the spleen cells from BALB/C mice immunized with high potency and low value of IC50 are fused with murine myeloma cells; and then the hybridoma cell line is obtained through indirect competitive ELISA screening and three subclones. The monoclonal antibody secreted by this cell line has good specificity and detection sensitivity to clarithromycin (value of IC50 is 0.3 ng/ml), being suitable for detection of clarithromycin in food.
    Type: Application
    Filed: April 25, 2019
    Publication date: September 19, 2019
    Inventors: Chuanlai XU, Hua KUANG, Lu ZENG, Liguang XU, Liqiang LIU, Shanshan SONG, Xiaoling WU, Yongming HU
  • Patent number: 10323100
    Abstract: A hybridoma cell line of secreting clarithromycin monoclonal antibodies with a preservation number of hybridoma cell line of CGMCC No. 14696 belongs to the field of food safety immunological detection. BALB/c mice are immunized through one time immunization with complete freund's adjuvant, three times of booster immunization with incomplete freund's adjuvant and one time of rush immunization with clarithromycin complete antigen without adjuvant; the spleen cells from BALB/C mice immunized with high potency and low value of IC50 are fused with murine myeloma cells; and then the hybridoma cell line is obtained through indirect competitive ELISA screening and three subclones. The monoclonal antibody secreted by this cell line has good specificity and detection sensitivity to clarithromycin (value of IC50 is 0.3 ng/ml), being suitable for detection of clarithromycin in food.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: June 18, 2019
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Chuanlai Xu, Hua Kuang, Lu Zeng, Liguang Xu, Liqiang Liu, Shanshan Song, Xiaoling Wu, Yongming Hu
  • Publication number: 20180226022
    Abstract: The disclosure provides a pixel driving circuit, including an organic light-emitting diode, a driving transistor driving the organic light-emitting diode, a first transistor controlled by a first scanning signal, a second transistor controlled by a second scanning signal, a first capacitor connected between a first node and a maintaining node, a second capacitor connected between the first node and a second node, a third capacitor connected between the maintaining node and the second node. The driving transistor includes a first node that forms a gate node, a second node connected to the organic light-emitting diode and a third node connected to a driving voltage line. The first transistor is connected between a reset voltage line and the first node. The second transistor is connected between the maintaining node and a data line. The current of an organic light-emitting diode and a threshold voltage of a driving transistor are unrelated.
    Type: Application
    Filed: January 18, 2017
    Publication date: August 9, 2018
    Applicant: Shenzhen China Star Optoelectronics Technology Co., Ltd.
    Inventor: Xiaoling WU
  • Patent number: D865264
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: October 29, 2019
    Assignee: Ningbo Joining Electronic Technology Co., Ltd
    Inventor: Xiaoling Wu
  • Patent number: D890977
    Type: Grant
    Filed: November 9, 2018
    Date of Patent: July 21, 2020
    Inventor: Xiaoling Wu
  • Patent number: D909652
    Type: Grant
    Filed: December 24, 2019
    Date of Patent: February 2, 2021
    Inventor: Xiaoling Wu